Adherence to roflumilast under dose-escalation strategy in Korean patients with COPD

BACKGROUND: Frequent development of adverse events and consequent low adherence are major barriers in the wide use of roflumilast. Asian patients may be more susceptible to adverse events due to low BMI. In this study, we aimed to determine if a dose-escalation strategy is useful to improve the drug...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Tai Sun, Kang, Jieun, Lee, Jae Seung, Oh, Yeon-Mok, Lee, Sang-Do, Lee, Sei Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580853/
https://www.ncbi.nlm.nih.gov/pubmed/31354255
http://dx.doi.org/10.2147/COPD.S191033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6580853/
https://www.ncbi.nlm.nih.gov/pubmed/31354255
http://dx.doi.org/10.2147/COPD.S191033

Ejemplares similares